Discover the latest insights from IQVIA on the financial impact of the 340B rebate model for hospitals and pharmacies. This fact sheet quantifies financing costs, compares rebate and inventory models, and addresses common concerns about the 340B Drug Pricing Program. Learn how rebate models affect cash flow, see key findings from sensitivity analyses, and understand why the new approach may offer cost advantages over traditional methods.

Key Highlights:

• Analysis of 340B rebate pilot and inventory models
• Financing costs for hospitals and federal grantees
• Interest cost comparisons using real-world data
• Conclusions on financial burden and cost savings

Download the full fact sheet to get actionable data and expert perspectives on 340B rebates and cash flow management.